<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>DISEASE CHARACTERISTICS: <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is a growth disorder characterized by <z:hpo ids='HP_0001520'>macrosomia</z:hpo>, <z:hpo ids='HP_0000158'>macroglossia</z:hpo>, <z:hpo ids='HP_0003271'>visceromegaly</z:hpo>, <z:hpo ids='HP_0002898'>embryonal tumors</z:hpo> (e.g., <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo>, <z:hpo ids='HP_0002884'>hepatoblastoma</z:hpo>, <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>, and <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo>), <z:hpo ids='HP_0001539'>omphalocele</z:hpo>, <z:hpo ids='HP_0001998'>neonatal hypoglycemia</z:hpo>, ear creases/pits, <z:hpo ids='HP_0008186'>adrenocortical cytomegaly</z:hpo>, and renal abnormalities (e.g., medullary <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:hpo ids='HP_0000121'>nephrocalcinosis</z:hpo>, <z:e sem="disease" ids="C0022681" disease_type="Disease or Syndrome" abbrv="">medullary sponge kidney</z:e>, and nephromegaly) </plain></SENT>
<SENT sid="1" pm="."><plain>Early <z:hpo ids='HP_0011420'>death</z:hpo> may occur from complications of <z:e sem="disease" ids="C0728731" disease_type="Disease or Syndrome" abbrv="">prematurity</z:e>, <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, <z:hpo ids='HP_0000158'>macroglossia</z:hpo>, or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000158'>Macroglossia</z:hpo> and <z:hpo ids='HP_0001520'>macrosomia</z:hpo> are generally present at birth but may have postnatal <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Growth rate slows around age seven to eight years </plain></SENT>
<SENT sid="5" pm="."><plain>Hemihyperplasia may affect segmental regions of the body or selected organs and tissues </plain></SENT>
<SENT sid="6" pm="."><plain>DIAGNOSIS/TESTING: A provisional diagnosis of BWS based on clinical assessment may be confirmed by molecular/cytogenetic testing </plain></SENT>
<SENT sid="7" pm="."><plain>Cytogenetically detectable abnormalities involving chromosome 11p15 are found in 1% or fewer of affected individuals </plain></SENT>
<SENT sid="8" pm="."><plain>Clinically available molecular genetic testing can identify epigenetic and genomic alterations of chromosome 11p15 in individuals with BWS: (1) loss of methylation on the maternal chromosome at imprinting center 2 (IC2) in 50% of affected individuals; (2) paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> for chromosome 11p15 in 20%; and (3) gain of methylation on the maternal chromosome at imprinting center 1 (IC1) in 5% </plain></SENT>
<SENT sid="9" pm="."><plain>Methylation alterations that are associated with microdeletions or microduplications in this region are associated with high heritability </plain></SENT>
<SENT sid="10" pm="."><plain>Sequence analysis of CDKN1C identifies mutations in approximately 40% of familial cases and 5%-10% of cases with no family history of BWS </plain></SENT>
<SENT sid="11" pm="."><plain>MANAGEMENT: Treatment of manifestations: Treatment of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> to reduce the risk of central <z:mp ids='MP_0008912'>nervous</z:mp> system complications; abdominal wall repair for <z:hpo ids='HP_0001539'>omphalocele</z:hpo>; endotracheal intubation for a compromised airway and use of specialized nipples or nasogastric tube feedings to manage <z:hpo ids='HP_0011968'>feeding difficulties</z:hpo> resulting from <z:hpo ids='HP_0000158'>macroglossia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Children with <z:hpo ids='HP_0000158'>macroglossia</z:hpo> may benefit from tongue reduction surgery in infancy or early childhood and from <z:e sem="disease" ids="C0009460,C0699719,C0037831" disease_type="Mental or Behavioral Dysfunction;Therapeutic or Preventive Procedure;Finding" abbrv="">speech therapy</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Surgery may be performed during <z:e sem="disease" ids="C0034013" disease_type="Disease or Syndrome" abbrv="">early puberty</z:e> to equalize significant differences in leg lengths secondary to hemihyperplasia; craniofacial surgery may benefit individuals with facial hemihyperplasia </plain></SENT>
<SENT sid="14" pm="."><plain><z:hpo ids='HP_0002664'>Neoplasias</z:hpo> are treated using standard pediatric <z:hpo ids='HP_0002664'>oncology</z:hpo> protocols </plain></SENT>
<SENT sid="15" pm="."><plain><z:hpo ids='HP_0000121'>Nephrocalcinosis</z:hpo> and other renal findings should be assessed and treated by a pediatric nephrologist </plain></SENT>
<SENT sid="16" pm="."><plain>Prevention of secondary complications: annual renal ultrasound examination for affected individuals between age eight years and mid-adolescence to identify those with <z:hpo ids='HP_0000121'>nephrocalcinosis</z:hpo> or <z:hpo ids='HP_0100956'>medullary sponge kidney disease</z:hpo> </plain></SENT>
<SENT sid="17" pm="."><plain>Surveillance: Monitor for <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, especially in the neonatal period; screen for <z:hpo ids='HP_0002898'>embryonal tumors</z:hpo> by abdominal ultrasound examination every three months until age eight years; monitor serum alpha-fetoprotein (AFP) concentration every two to three months in the first four years of life for early detection of <z:hpo ids='HP_0002884'>hepatoblastoma</z:hpo> </plain></SENT>
<SENT sid="18" pm="."><plain>GENETIC COUNSELING: <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> is associated with abnormal regulation of gene transcription in the imprinted domain on chromosome 11p15.5 </plain></SENT>
<SENT sid="19" pm="."><plain>Most individuals with BWS are reported to have <z:mpath ids='MPATH_458'>normal</z:mpath> chromosome studies or karyotypes </plain></SENT>
<SENT sid="20" pm="."><plain>Approximately 85% of individuals with BWS have no family history of BWS while approximately 15% have a family history consistent with <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> transmission of BWS </plain></SENT>
<SENT sid="21" pm="."><plain>Children of <z:mp ids='MP_0001921'>subfertile</z:mp> parents conceived by assisted reproductive technology (ART) may have an increased risk for imprinting disorders, including BWS </plain></SENT>
<SENT sid="22" pm="."><plain>Identification of the underlying genetic mechanism causing BWS permits better estimation of recurrence risk </plain></SENT>
<SENT sid="23" pm="."><plain>Prenatal screening for pregnancies not previously known to be at increased risk for BWS by ultrasound examination and maternal serum alpha-fetoprotein assay may lead to the consideration of chromosome analysis and/or molecular genetic testing </plain></SENT>
<SENT sid="24" pm="."><plain>Specific prenatal testing is possible by chromosome analysis for families with an inherited chromosome abnormality or by molecular genetic testing for families in which the molecular mechanism of BWS has been defined </plain></SENT>
</text></document>